Skip to main content
. 2018 Dec 14;16:357. doi: 10.1186/s12967-018-1741-y

Table 6.

Top 50 predicted miRNAs associated with breast neoplasms based on known associations in HMDD

Rank miRNA Evidence Rank miRNA Evidence
1 hsa-mir-21 HMDD; I; II; III; IV 26 hsa-mir-29a HMDD; I; II; IV
2 hsa-mir-155 HMDD; I; II; III; IV 27 hsa-mir-92a-2 HMDD; I; II
3 hsa-mir-17 HMDD; I; II; III 28 hsa-mir-223 HMDD; I; II; IV
4 hsa-mir-20a HMDD; I; II; III 29 hsa-mir-181a-1 HMDD; I; II; III
5 hsa-mir-125b-1 HMDD; I; II; III; IV 30 hsa-mir-29b-1 HMDD; I; II; III
6 hsa-mir-92a-1 HMDD; I; II 31 hsa-let-7b HMDD; I; II
7 hsa-mir-18a HMDD; I; II; III 32 hsa-mir-200c HMDD; I; II; III
8 hsa-mir-145 HMDD; I; II; III 33 hsa-mir-29c HMDD; I; II; III
9 hsa-mir-16-1 HMDD; I; II 34 hsa-mir-181a-2 HMDD; I; II; III
10 hsa-mir-34a HMDD; I; II; IV 35 hsa-mir-200a HMDD; I; II; III; IV
11 hsa-mir-19b-1 HMDD; I; II; IV 36 hsa-mir-29b-2 HMDD; I; II; III
12 hsa-mir-125b-2 HMDD; I; II; III; IV 37 hsa-let-7c HMDD; I; II
13 hsa-mir-146a HMDD; I; II; III; IV 38 hsa-mir-19b-2 I; II; IV
14 hsa-mir-19a HMDD; I; II; IV 39 hsa-mir-150 I; II
15 hsa-mir-16-2 HMDD; I; II 40 hsa-mir-210 HMDD; I; II; III
16 hsa-mir-221 HMDD; I; II; III 41 hsa-mir-34c HMDD; I
17 hsa-let-7a-1 HMDD; I; II; III 42 hsa-mir-1-1 HMDD; I; II; IV
18 hsa-mir-143 HMDD; I; II; III 43 hsa-let-7d HMDD; I; II; III
19 hsa-let-7a-3 HMDD; I; II; III 44 hsa-mir-182 HMDD; I; II; III
20 hsa-mir-126 HMDD; I; II; III 45 hsa-mir-214 HMDD; I; II; IV
21 hsa-mir-15a HMDD; I; II 46 hsa-mir-9-1 HMDD; I; II; III; IV
22 hsa-mir-31 HMDD; I; II; III 47 hsa-mir-106b HMDD; I; II
23 hsa-let-7a-2 HMDD; I; II; III 48 hsa-mir-142 I; II; IV
24 hsa-mir-200b HMDD; I; II; III; IV 49 hsa-let-7i HMDD; I; II; III
25 hsa-mir-222 HMDD; I; II; III 50 hsa-mir-181b-1 HMDD; I; II; III; IV

I, II, III and IV represent dbDEMC, PhenomiR, miR2Disease and miRwayDB, respectively